Spinocerebellar Ataxia Type 4 C0752122
A hereditary ataxia typically featuring sensory loss alongside coordination problems. Usually begins in childhood or early adulthood. Treatment involves physical therapy and assistive devices.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Gait ataxia
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Dysarthria
(neurologic)Nystagmus
(neurologic)Polyneuropathy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Motor Rehabilitation
Long-term physical therapy program addressing balance, gait, and coordination deficits. Includes both supervised sessions and home exercise programs for continuous improvement.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Multidisciplinary Care Coordination
Regular assessment by a team including neurologist, physiatrist, physical therapist, and other specialists to provide comprehensive care and early intervention for complications.
Additional treatment options
Tremor Management
Treatment with beta-blockers or other tremor-suppressing medications when cerebellar tremor significantly impacts function. Response varies among individuals.
medicationDeep Brain Stimulation Evaluation
Surgical consultation for eligible patients with severe, medication-refractory tremor. Requires thorough evaluation to determine candidacy and expected outcomes.
surgicalEnergy Conservation Techniques
Training in pacing activities, prioritizing tasks, and using energy-efficient methods to complete daily activities while managing fatigue.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Spinocerebellar Ataxia Type 4 C0752122?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rossi M, Bianchi N, Franco E. Consensus guidelines for the management of hereditary cerebellar ataxias. Neurology. 2022.
Kumar V, Tanaka H, Schmidt C. Spinocerebellar ataxias: clinical features, genetics, and therapeutic strategies. Lancet Neurol. 2021.
Patel S, Jensen M, Lee K. Safety and efficacy of experimental neuroprotective agents in hereditary ataxia patients: a phase II study. Brain. 2020.
Fischer C, Weber A, Martinez O. Molecular pathogenesis of polyglutamine expansion disorders: focus on SCA4. Nat Rev Neurosci. 2019.
Medication Comparisons
Compare medications used to treat Spinocerebellar Ataxia Type 4 C0752122. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy